Rockwell Medical (RMTI) Capital Expenditures Growth (3y) (2013 - 2026)
Rockwell Medical (RMTI) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 91.93 Bn | 90.07 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.31 Bn | 32.57 Bn | 1.97 Bn | 6.52% |
| 3 | Zoetis | 33.01 Bn | 31.07 Bn | 1.62 Bn | 232.22% |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn | 1.64% |
| 5 | United Therapeutics | 22.96 Bn | 20.81 Bn | 648.10 Mn | 75.58% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.50 Bn | 18.69 Bn | 1.16 Bn | -5.84% |
| 8 | Neurocrine Biosciences | 18.16 Bn | 16.85 Bn | 800.70 Mn | 32.64% |
| 9 | Elanco Animal Health | 12.84 Bn | 12.41 Bn | 785.00 Mn | 28.56% |
| 10 | Rockwell Medical | 27.87 Mn | 3.98 Mn | 2.90 Mn | 43.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.11% |
| Dec 31, 2025 | -32.61% |
| Sep 30, 2025 | 69.42% |
| Jun 30, 2025 | 47.60% |
| Mar 31, 2025 | 29.51% |
| Dec 31, 2024 | 51.32% |
| Sep 30, 2024 | 14.57% |
| Jun 30, 2024 | 5.58% |
| Mar 31, 2024 | 54.08% |
| Dec 31, 2023 | -17.29% |
| Sep 30, 2023 | -71.44% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -10.61% |
| Dec 31, 2022 | 26.44% |
| Sep 30, 2022 | -36.72% |
| Jun 30, 2022 | -34.71% |
| Mar 31, 2022 | -38.02% |
| Dec 31, 2021 | -9.68% |
| Sep 30, 2021 | -20.07% |
| Jun 30, 2021 | 9.50% |